Epidemiology and management of patients with pulmonary arterial hypertension associated with congenital heart disease: data from the hellenic pulmonary hypertension registry (HOPE)

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speakers

Doctor Alexandra Arvanitaki

Aristotle University of Thessaloniki, Thessaloniki (Greece)

Mr Ioannis Farmakis

Ludwig Maximilians University, Munich (Germany)

7 More presentations in this session

Presentation thumbnail

Effect of a short course of parenteral treprostinil therapy on right heart structure and function in pulmonary arterial hypertension

Doctor C. Vizza (Rome, IT)

Abstract Slides Video

Presentation thumbnail

Triple therapy for incident pulmonary arterial hypertension in Finland between 2008 and 2020. A descriptive real-world FINPAH cohort study

Doctor M. Pentikainen (Helsinki, FI)

Abstract Slides Video

Presentation thumbnail

Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE

Professor P. Jansa (Prague, CZ)

Abstract Slides Video

Presentation thumbnail

The effect of sildenafil on maternal mortality in pulmonary arterial hypertension associated with congenital heart disease

Doctor N. Nahdi (Yogyakarta, ID)

Abstract Slides Video

Presentation thumbnail

Efficacy comparison of prostacyclin analogue and prostacyclin receptor agonist as third line treatment for pulmonary arterial hypertension

Doctor G. martini (Bologna, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Current treatment of pulmonary hypertension: it is all about vasodilators

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources